Accent Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Accent Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	1,056 +977	+1,237%	+$469K	0.23%	57
2026 Q1	$38.8K	Buy	79 +54	+216%	+$29.3K	0.02%	120
2025 Q4	$14.5K	Hold	25	–	–	0.01%	162
2025 Q3	$12.1K	Sell	25 -916	-97%	-$426K	0.01%	189
2025 Q2	$382K	Buy	941 +25	+3%	+$10.5K	0.17%	51
2025 Q1	$456K	Buy	916 +62	+7%	+$33.6K	0.26%	41
2024 Q4	$445K	Hold	854	–	–	0.25%	41
2024 Q3	$529K	Sell	854 -721	-46%	-$427K	0.3%	38
2024 Q2	$871K	Buy	+1,575	New	+$902K	0.53%	27
2024 Q1	–	Sell	-1,575	Closed	-$836K	–	191
2023 Q4	$836K	Buy	+1,575	New	+$762K	0.66%	27

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Accent Capital Management's TMO Position: Q2 2026 in Review

Accent Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1,237% in Q2 2026, buying an estimated $469K and bringing the position to 1,056 shares worth $529K. The position accounts for 0.23% of the portfolio, ranked #57.

Accent Capital Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $871K in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Accent Capital Management held 1,056 shares of Thermo Fisher Scientific worth $529K as of Q2 2026.
Accent Capital Management bought 977 Thermo Fisher Scientific shares in Q2 2026, an estimated $469K.
Thermo Fisher Scientific made up 0.23% of Accent Capital Management's portfolio in Q2 2026, its #57 holding.
Accent Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
Accent Capital Management's Thermo Fisher Scientific position peaked at $871K in Q2 2024.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.